Robin is a Director of Biostatistics at Veristat. She oversees the operations of the biostatistics department and collaborates with all the integrated operational teams throughout the clinical trial and regulatory submission process to help produce high quality statistical deliverables.
She has over 12 years of experience in clinical biostatistics, is very experienced with designing and implementing adaptive clinical trials. Robin has worked with both the United States Food & Drug Administration (FDA) and Japan's Pharmaceutical and Medical Devices Agency (PMDA) to defend adaptive design trials for clients. Her knowledge and expertise span a broad range of therapeutic and product indications including oncology, rare diseases, vaccines and devices/diagnostics. Throughout her career, Robin has participated in over 30 publications and continues to provide peer review for a variety of organizations. She earned her PhD and MA from Boston University and her BA in Mathematics from Williams College in Williamstown, MA.